Literature DB >> 27136441

The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset.

Katia Chieregato1,2, Cristina Zanon1, Silvia Castegnaro1, Martina Bernardi1,2, Eliana Amati1, Sabrina Sella1, Francesco Rodeghiero1,2, Giuseppe Astori1.   

Abstract

BACKGROUND: Cytokine-induced killer cells are polyclonal T cells generated ex vivo and comprise two main subsets: the CD56- fraction, possessing an alloreactive potential caused by T cells (CD3+CD56-), and the CD56+ fraction, characterised by a strong antitumour capacity induced by natural killer-like T cells (NK-like T, CD3+CD56+) and natural killer cells (NK, CD3-CD56+ bright).
MATERIALS AND METHODS: We investigated the cytotoxic action of selected CD56+ cell subpopulations against a human chronic myeloid leukaemia (K562) cell line.
RESULTS: After immunomagnetic selection of the CD56+ cell fraction, NK bright cells (CD3-CD56+ bright) and two subsets of NK-like T cells (CD3+CD56+), called NK-like T CD56 dim and NK-like T CD56 bright, could be identified. The cytotoxic effect against K562 cells was mainly exerted by the NK bright subpopulation and resulted to be inversely correlated with the percentage of NK-like T CD56 dim cells in the culture. The lytic action appeared to be independent of cell degranulation as suggested by the lack of change in the expression of CD107a. DISCUSSION: We conclude that the cytotoxic action of CD56+ cells against a K562 cell line is mainly due to the NK cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27136441      PMCID: PMC5269434          DOI: 10.2450/2016.0263-15

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  21 in total

1.  Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.

Authors:  Selim Kuçi; Eva Rettinger; Bernhard Voss; Gerrit Weber; Miriam Stais; Hermann Kreyenberg; Andre Willasch; Zyrafete Kuçi; Ewa Koscielniak; Stephan Klöss; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

2.  Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.

Authors:  Alice Pievani; Gianmaria Borleri; Daniela Pende; Lorenzo Moretta; Alessandro Rambaldi; Josée Golay; Martino Introna
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

3.  Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.

Authors:  M R Verneris; M Kornacker; V Mailänder; R S Negrin
Journal:  Cancer Immunol Immunother       Date:  2000-08       Impact factor: 6.968

4.  Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion.

Authors:  Eva Rettinger; Hermann Kreyenberg; Michael Merker; Selim Kuçi; Andre Willasch; Gesine Bug; Evelyn Ullrich; Winfried S Wels; Halvard Bonig; Thomas Klingebiel; Peter Bader
Journal:  Cytotherapy       Date:  2014-02-28       Impact factor: 5.414

5.  Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.

Authors:  Ludovic Durrieu; William Lemieux; Mame Massar Dieng; François Fontaine; Michel Duval; Françoise Le Deist; Elie Haddad
Journal:  Cytotherapy       Date:  2014-02-12       Impact factor: 5.414

6.  Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells.

Authors:  G Bossi; G M Griffiths
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

Review 7.  Killer immunoglobulin-like receptors.

Authors:  Lorenzo Moretta; Alessandro Moretta
Journal:  Curr Opin Immunol       Date:  2004-10       Impact factor: 7.486

Review 8.  Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.

Authors:  A Rambaldi; E Biagi; C Bonini; A Biondi; M Introna
Journal:  Leukemia       Date:  2014-06-12       Impact factor: 11.528

9.  Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells.

Authors:  Malin Hedlund; Olga Nagaeva; Dominic Kargl; Vladimir Baranov; Lucia Mincheva-Nilsson
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

10.  Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

Authors:  Yenan T Bryceson; Michael E March; Domingo F Barber; Hans-Gustaf Ljunggren; Eric O Long
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

View more
  1 in total

Review 1.  Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.

Authors:  Yutao Li; Amit Sharma; Jarek Maciaczyk; Ingo G H Schmidt-Wolf
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.